BST2 and cancer: Given that BST-2 is present in all breast tumors at different levels, and our results show that the effect of B49Mod1 is operative in all cancer cells tested, it seems that the role of BST-2 in breast cancer may be subtype independent and that B49Mod1 may be effective on all breast cancer subtypes.